Impact of Incidental Amyloidosis on the Prognosis of Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction-Reference-Cited by-同舟云学术

Impact of Incidental Amyloidosis on the Prognosis of Patients With Hypertrophic Cardiomyopathy Undergoing Septal Myectomy for Left Ventricular Outflow Tract Obstruction

Published:2014-11 Issue:9 Volume:114 Page:1396-1399
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Helder Meghana R.K.,Schaff Hartzell V.,Nishimura Rick A.,Gersh Bernard J.,Dearani Joseph A.,Ommen Steve R.,Mereuta Oana M.,Theis Jason D.,Dogan Ahmet,Edwards William D.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Use of percutaneous transluminal septal myocardial ablation for relief of outflow tract obstruction in cardiac amyloidosis: a novel therapeutic target;Murphy;Catheter Cardiovasc Interv,2006

2. The premortem recognition of systemic senile amyloidosis with cardiac involvement;Kyle;Am J Med,1996

3. Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy;Dinwoodey;Am J Cardiol,2008

4. Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy: a study of 204 cases (1996-2000);Lamke;Cardiovasc Pathol,2003

5. Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: a study of 98 cases (1996-2000);Allen;Cardiovasc Pathol,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A propensity-matched analysis of cardiac operation in patients with and without cardiac amyloidosis;JTCVS Open;2024-08

2. The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis;Heart Failure Clinics;2024-07

3. ATTR- and AFib amyloid - two different types of amyloid in the annular ligament of trigger finger;Amyloid;2023-06-23

4. Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy;Circulation: Cardiovascular Imaging;2022-12

5. Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort;Journal of Managed Care & Specialty Pharmacy;2022-07